Page last updated: 2024-08-23

silybin and Leukemia, Lymphocytic, T Cell

silybin has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amirghofran, Z; Gharagozloo, M; Khoshdel, Z	1

Other Studies

1 other study(ies) available for silybin and Leukemia, Lymphocytic, T Cell

Article	Year
The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine. European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3 Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Deferoxamine; DNA Replication; Dose-Response Relationship, Drug; Humans; Iron; Iron Chelating Agents; Jurkat Cells; Leukemia, T-Cell; Silybin; Silymarin; Time Factors	2008

Article

Year

The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine.

European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

Topics: Antioxidants; Apoptosis; Cell Cycle; Cell Proliferation; Cell Survival; Deferoxamine; DNA Replication; Dose-Response Relationship, Drug; Humans; Iron; Iron Chelating Agents; Jurkat Cells; Leukemia, T-Cell; Silybin; Silymarin; Time Factors

2008